molecular diagnostics
Through detailed molecular diagnosis, subgroups of diseases can be defined and targeted treatments can be developed. For example, it is thus possible to treat patients with cancer or autoimmune diseases with very specific acting therapeutic antibodies.
The company BioTeZ Berlin-Buch GmbH has developed a monitoring system with which for the first time physicians can determine during treatment what effect the drug has on the individual patient and what dosage he/she still needs. Thus, the treatment can be optimized for the individual patient, which may in the end also be much more cost effective.
INVITEK Molecular GmbH offers customized solutions for the manual and automatic preparation of samples for molecular biological diagnostic methods, such as DNA and RNA analysis. Nucleic acid isolation and purification are offered by IST Innuscreen GmbH. The company’s portfolio also includes molecular biological reagent systems as well as technologies and products for molecular diagnostics.
Molecular diagnostics also have applications in food technology: The company aokin AG is specialized in rapid precision analysis of toxins: With the aokin system, mold in grain shipments can be identified within minutes. Congen Biotechnologie GmbH develops and produces PCR-based detection methods for agricultural and food analysis. This makes it possible to identify genetically modified plants, allergens or pathogenic bacteria and viruses.
News innovation
Pentixapharm Acquires Target Discovery Business of Glycotope
Pentixapharm AG, a clinical-stage biotech company discovering and developing novel targeted radiopharmaceuticals against a range of malignancies, has announced the execution of an agreement, effective...
more ...Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG, a clinical-stage biotech company discovering and developing novel targeted radiopharmaceuticals against a broad range of malignancies, announced today that the General Shareholder Mee...
more ...Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today resolved to split-off Pentixapharm AG from Eckert & Ziegler SE and to distribute a dividend of EUR 0.05 per share for the 20...
more ...Events Campus
10.09.2024, 09:00
From Target to Market - The GLA Biotech & Pharma Summer School
The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea to the market.
more ...12.09.2024, 09:00
Realtime PCR und digital PCR Kurs
Der RealTime PCR und Digital PCR Kurs richtet sich an erfahrene PCR Anwender*innen und an Einsteiger*innen. Wichtige PCR Grundlagen werden erörtert, bevor die RealTime PCR besprochen und Genexpression...
more ...08.10.2024, 09:00
GMP Biotech Summer School
Good Manufacturing Practice (GMP) Basic Course Biotechnology (English) & ATMPs
more ...
